Ebi N, Inoue H, Igata F, Okuma R, et al. Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy. Anticancer Res 2024;44:3087-3095.
PMID: 38925810